Drug Shortage Report for ACT CIPROFLOXACIN
Report ID | 149931 |
Drug Identification Number | 02247339 |
Brand name | ACT CIPROFLOXACIN |
Common or Proper name | CIPROFLOXACIN 250MG FC TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-11-24 |
Estimated end date | 2023-10-10 |
Actual end date | 2023-10-04 |
Shortage status | Resolved |
Updated date | 2023-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2022-11-14 | French | Compare |
v22 | 2023-01-12 | English | Compare |
v23 | 2023-01-12 | French | Compare |
v24 | 2023-01-18 | English | Compare |
v25 | 2023-01-18 | French | Compare |
v26 | 2023-01-19 | English | Compare |
v27 | 2023-01-19 | French | Compare |
v28 | 2023-02-02 | English | Compare |
v29 | 2023-02-02 | French | Compare |
v30 | 2023-10-04 | English | Compare |
v31 | 2023-10-04 | French | Compare |
v32 | 2023-10-05 | English | Compare |
v33 | 2023-10-05 | French | Compare |